An approvable letter is sent by the FDA when a drugmaker's New Drug Application is not sufficient for approval, but has the potential to be approved at a later date. The letter spells out what problems the FDA had with the marketing application. Often times further meetings with the FDA are required to determine what needs to be done to get the drug approved.
Recent Mentions on Fool.com
- Why Are Comcast's Data Cap Exemptions Evil If T-Mobile's Are A-OK?
- Gilead Sciences Grabs 4 Regulatory Wins -- but Does It Matter?
- 5 Things Pfizer Inc. Wants You to Know
- Why Angie's List Inc. Jumped On Thursday
- Surprise! This Obamacare Problem Still Hasn't Been Resolved
- Pfizer Handily Surpasses Estimates, but This CEO Comment Is Troubling